A Japanese case report of co-localized psoriasis and vitiligo reveals that IL-23 blockade cleared psoriasis but not vitiligo, ...

<?xml encoding="utf-8" ?> Arcutis Biotherapeutics, Inc. ARQT stock traded higher Thursday after Cantor Fitzgerald initiated ...

While dermatologists prescribe coal tar shampoos for specific scalp conditions, it’s important to understand when and how ...

While having high blood pressure or high cholesterol may seem like more obvious heart disease risk factors, your skin may be able to predict your risk too.

Zasocitinib demonstrated superiority over deucravacitinib for the treatment of moderate to severe plaque psoriasis, according ...

PRNewswire/ -- (NYSE: JNJ) today announced new two-year results from the Phase 3 ICONIC-LEADa study evaluating ICOTYDE® (icotrokinra), ...

Dandruff is one of the most common scalp concerns, and it can cause visible flakes, itching, dryness, or irritation. While it ...

Data on access barriers to see a dermatologist has accumulated and compounded over the last decade without a consistent trend ...

A new pharmacokinetic review explains why the safety warnings attached to topical roflumilast, drawn largely from its oral ...

Pills that rival biologics, weight-loss drugs paired with psoriasis treatment and a phase 3 win for a personalized mRNA ...

Zasocitinib was 2.5 times more effective than deucravacitinib at helping patients with plaque psoriasis achieve completely clear skin, based on the first head-to-head test.

A man with 3 years of high-volume energy drink consumption presents with jaundice and mixed liver injury, with biopsy showing ...